This company listing is no longer active
Laboratorio Reig Jofre Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Laboratorio Reig Jofre has a total shareholder equity of €188.5M and total debt of €47.4M, which brings its debt-to-equity ratio to 25.1%. Its total assets and total liabilities are €325.0M and €136.5M respectively. Laboratorio Reig Jofre's EBIT is €9.3M making its interest coverage ratio 14.7. It has cash and short-term investments of €6.0M.
Anahtar bilgiler
25.1%
Borç/özkaynak oranı
€47.40m
Borç
Faiz karşılama oranı | 14.7x |
Nakit | €6.04m |
Eşitlik | €188.51m |
Toplam yükümlülükler | €136.46m |
Toplam varlıklar | €324.98m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: RJF.D's short term assets (€108.8M) exceed its short term liabilities (€74.9M).
Uzun Vadeli Yükümlülükler: RJF.D's short term assets (€108.8M) exceed its long term liabilities (€61.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: RJF.D's net debt to equity ratio (21.9%) is considered satisfactory.
Borcun Azaltılması: RJF.D's debt to equity ratio has increased from 18.5% to 25.1% over the past 5 years.
Borç Kapsamı: RJF.D's debt is well covered by operating cash flow (30.6%).
Faiz Kapsamı: RJF.D's interest payments on its debt are well covered by EBIT (14.7x coverage).